Free Trial

Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume

$0.14
+0.01 (+7.55%)
(As of 07/12/2024 ET)

Galera Therapeutics Short Interest Data

Current Short Interest
1,910,000 shares
Previous Short Interest
2,120,000 shares
Change Vs. Previous Month
-9.91%
Dollar Volume Sold Short
$410,841.00
Short Interest Ratio
1.1 Days to Cover
Last Record Date
May 31, 2024
Outstanding Shares
54,390,000 shares
Float Size
34,820,000 shares
Short Percent of Float
5.49%
Today's Trading Volume
143,138 shares
Average Trading Volume
455,656 shares
Today's Volume Vs. Average
31%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Galera Therapeutics ?

Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GRTX Short Interest Over Time

GRTX Days to Cover Over Time

GRTX Percentage of Float Shorted Over Time

Galera Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20241,910,000 shares $410,841.00 -9.9%5.5%1.1 $0.22
5/15/20242,120,000 shares $402,800.00 -24.0%6.1%1 $0.19
4/30/20242,790,000 shares $519,777.00 +4.9%7.3%1.4 $0.19
4/15/20242,660,000 shares $406,714.00 +50.3%6.5%1.4 $0.15
3/31/20241,770,000 shares $247,800.00 -36.8%4.1%0.7 $0.14
3/15/20242,800,000 shares $591,360.00 -45.0%7.3%1.4 $0.21
2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24
2/15/20243,360,000 shares $613,200.00 -4.0%8.6%1.7 $0.18
1/31/20243,500,000 shares $626,500.00 -24.6%9.9%1.9 $0.18
1/15/20244,640,000 shares $997,600.00 +197.4%13.1%1.4 $0.22
12/31/20231,560,000 shares $226,824.00 +12.2%3.7%0.4 $0.15
12/15/20231,390,000 shares $190,430.00 +1.5%3.3%0.4 $0.14
11/30/20231,370,000 shares $195,225.00 -24.7%3.5%0.3 $0.14
11/15/20231,820,000 shares $263,172.00 -36.6%4.5%0.4 $0.14
10/31/20232,870,000 shares $278,677.00 -1.0%8.0%0.5 $0.10
10/15/20232,900,000 shares $553,900.00 -18.3%8.1%0.6 $0.19
9/30/20233,550,000 shares $621,605.00 +73.2%9.9%1 $0.18
9/15/20232,050,000 shares $386,630.00 -15.6%5.7%0.6 $0.19
8/31/20232,430,000 shares $510,300.00 -27.7%6.8%1 $0.21
8/15/20233,360,000 shares $906,864.00 +128.6%9.4%1.4 $0.27
7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46
7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75
6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12
6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39
5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07
5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18
10/31/2022610,400 shares $885,080.00 +17.4%3.4%5 $1.45
10/15/2022519,800 shares $805,690.00 -2.5%2.9%6 $1.55
9/30/2022533,100 shares $927,594.00 +4.5%2.9%6.1 $1.74
9/15/2022510,200 shares $954,074.00 +8.5%2.8%5.4 $1.87
8/31/2022470,100 shares $629,934.00 +2.0%2.6%5.1 $1.34
8/15/2022460,900 shares $672,914.00 -4.9%2.5%5.5 $1.46
7/31/2022484,800 shares $562,368.00 -0.6%2.7%4.7 $1.16
7/15/2022487,900 shares $585,480.00 -8.7%2.7%3.7 $1.20
6/30/2022534,400 shares $694,720.00 -4.0%3.0%3.8 $1.30
6/15/2022556,700 shares $823,916.00 -6.2%3.1%3.8 $1.48
5/31/2022593,500 shares $949,600.00 +11.4%3.3%3.3 $1.60
5/15/2022533,000 shares $804,830.00 -17.5%2.9%2.4 $1.51
4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69
4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13
Billionaire opens new pathway to wealth for investors (Ad)

I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.

Watch now
3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38
3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10
2/28/2022640,700 shares $1.44 million +115.7%3.6%0.1 $2.24
2/15/2022297,000 shares $694,980.00 +93.7%1.7%0 $2.34
1/31/2022153,300 shares $420,042.00 -73.6%1.4%0 $2.74
1/15/2022580,700 shares $2.00 million -71.0%N/A0 $3.44
12/31/20212,000,000 shares $9.18 million +226.7%18.0%0.2 $4.59
12/15/2021612,100 shares $1.78 million -17.2%5.5%0.1 $2.90
11/30/2021739,100 shares $975,612.00 +14.6%7.1%0.2 $1.32
11/15/2021645,000 shares $1.08 million -57.6%6.2%0.2 $1.68
10/29/20211,520,000 shares $2.84 million +814.0%15.2%0.6 $1.87
10/15/2021166,300 shares $1.30 million +8.5%1.7%0.2 $7.81
9/30/2021153,300 shares $1.24 million -3.1%1.5%2.2 $8.10
9/15/2021158,200 shares $1.14 million -11.9%1.5%1.7 $7.18
8/31/2021179,600 shares $1.61 million -4.5%1.7%1.6 $8.96
8/13/2021188,100 shares $1.56 million -16.1%1.8%1.5 $8.30
7/30/2021224,200 shares $1.88 million -15.6%2.1%1.5 $8.38
7/15/2021265,600 shares $2.48 million -3.6%2.5%0.4 $9.34
6/30/2021275,500 shares $2.71 million -43.9%2.6%0.4 $9.83
6/15/2021490,900 shares $4.40 million +0.9%4.7%0.8 $8.96
5/28/2021486,600 shares $4.17 million -1.5%4.6%0.8 $8.57
5/14/2021494,000 shares $3.52 million +51.2%4.8%0.9 $7.12
4/30/2021326,700 shares $2.65 million +103.4%3.4%0.6 $8.12
4/15/2021160,600 shares $1.21 million +4.8%N/A0 $7.52
3/31/2021153,200 shares $1.28 million +6.0%1.6%2.3 $8.35
3/15/2021144,500 shares $1.59 million -2.0%1.5%2.2 $11.00
2/26/2021147,500 shares $1.55 million +13.5%1.5%2.1 $10.48
2/12/2021130,000 shares $1.54 million +12.9%1.3%1.9 $11.84
1/29/2021115,200 shares $1.22 million +25.6%1.4%1.7 $10.63
1/15/202191,700 shares $917,917.00 -18.7%1.1%1 $10.01
12/31/2020112,800 shares $1.22 million -5.7%1.4%1.5 $10.79
12/15/2020119,600 shares $1.29 million -1.0%1.4%1.3 $10.80
11/30/2020120,800 shares $1.35 million -10.8%1.5%1.5 $11.21
11/15/2020135,400 shares $1.38 million -4.1%1.6%1.8 $10.20
10/30/2020141,200 shares $1.24 million +63.8%1.7%2 $8.78
10/15/202086,200 shares $1.08 million -6.6%0.9%1.4 $12.50
9/30/202092,300 shares $834,392.00 -11.0%1.0%2.2 $9.04
9/15/2020103,700 shares $852,414.00 -8.2%1.1%2.5 $8.22
8/31/2020112,900 shares $881,749.00 -2.0%1.2%1.7 $7.81
8/14/2020115,200 shares $899,712.00 -1.5%1.2%1.6 $7.81
7/31/2020116,900 shares $813,624.00 -7.8%1.2%1.6 $6.96
7/15/2020126,800 shares $997,916.00 +4.4%1.3%1.8 $7.87
6/30/2020121,500 shares $982,935.00 -11.5%1.3%1.8 $8.09
6/15/2020137,300 shares $1.20 million +981.1%1.6%3 $8.72
5/29/202012,700 shares $132,842.00 -38.9%0.2%0.6 $10.46
5/15/202020,800 shares $228,800.00 +45.5%0.3%1.1 $11.00
4/30/202014,300 shares $206,063.00 -14.9%0.2%0.8 $14.41
4/15/202016,800 shares $176,400.00 -26.6%0.3%0.7 $10.50
3/31/202022,900 shares $292,204.00 -3.0%0.5%0.7 $12.76
3/13/202023,600 shares $242,608.00 -26.3%0.5%1 $10.28
Billionaire opens new pathway to wealth for investors (Ad)

I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.

Watch now
2/28/202032,000 shares $266,880.00 -21.0%0.6%0.6 $8.34
2/14/202040,500 shares $455,220.00 -12.3%0.8%0.7 $11.24
1/31/202046,200 shares $698,544.00 -10.6%0.7%0.6 $15.12
1/15/202051,700 shares $743,446.00 -8.7%0.7%0.5 $14.38
12/31/201956,600 shares $717,688.00 No Change0.9%0.5 $12.68

GRTX Short Interest - Frequently Asked Questions

What is Galera Therapeutics' current short interest?

Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 1,910,000 shares of GRTX short. 5.49% of Galera Therapeutics' shares are currently sold short. Learn More on Galera Therapeutics' current short interest.

What is a good short interest ratio for Galera Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRTX shares currently have a short interest ratio of 1.0. Learn More on Galera Therapeutics's short interest ratio.

What is a good short interest percentage for Galera Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.49% of Galera Therapeutics' floating shares are currently sold short.

Is Galera Therapeutics' short interest increasing or decreasing?

Galera Therapeutics saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 1,910,000 shares, a decrease of 9.9% from the previous total of 2,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Galera Therapeutics' float size?

Galera Therapeutics currently has issued a total of 54,390,000 shares. Some of Galera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galera Therapeutics currently has a public float of 34,820,000 shares.

How does Galera Therapeutics' short interest compare to its competitors?

5.49% of Galera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Galera Therapeutics: Enlivex Therapeutics Ltd. (0.56%), Bolt Biotherapeutics, Inc. (7.66%), RenovoRx, Inc. (0.19%), Acasti Pharma Inc. (0.03%), VYNE Therapeutics Inc. (0.45%), NRx Pharmaceuticals, Inc. (4.30%), Daré Bioscience, Inc. (0.42%), ImmunoPrecise Antibodies Ltd. (0.65%), BioVie Inc. (2.29%), Biora Therapeutics, Inc. (3.85%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Galera Therapeutics stock?

Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. GRTX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Galera Therapeutics?

A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further.

How often is Galera Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is May, 31 2024.



This page (NASDAQ:GRTX) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners